Guangzhou Medical University, formerly known as Guangzhou Medical College, is a Chinese medical school located in Guangzhou.

During the past decade, Affiliated Cancer Hospital and Institute of Guangzhou Medical University conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Affiliated Cancer Hospital and Institute of Guangzhou Medical University" #1 sponsor was "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 6 trials, followed by "Akeso" with 2 trials sponsored, "Jiangsu HengRui Medicine Co., Ltd." with 2 trials sponsored, "Sun Yat-sen University" with 2 trials sponsored and "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affiliated Cancer Hospital and Institute of Guangzhou Medical University" #1 collaborator was "Guangdong Provincial People's Hospital" with 3 trials as a collaborator, "Fifth Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator, "First People's Hospital of Foshan" with 2 trials as a collaborator and "Peking University Cancer Hospital & Institute" with 2 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Affiliated Cancer Hospital and Institute of Guangzhou Medical University" are "Nasopharyngeal Neoplasms" (2 trials), "Non Small Cell Lung Cancer" (2 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials), "Bone Marrow Diseases" (1 trials) and "Brain Metastasis" (1 trials). Many other conditions were trialed in "Affiliated Cancer Hospital and Institute of Guangzhou Medical University" in a lesser frequency.

Most popular intervention types in "Affiliated Cancer Hospital and Institute of Guangzhou Medical University" are "Drug" (15 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Penpulimab" (2 trials), "Amifostine every-other-day regimen" (1 trials), "Amifostine everyday regimen" (1 trials), "Anlotinib Hydrochloride Capsule" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Affiliated Cancer Hospital and Institute of Guangzhou Medical University" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Affiliated Cancer Hospital and Institute of Guangzhou Medical University". 2 are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Affiliated Cancer Hospital and Institute of Guangzhou Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Affiliated Cancer Hospital and Institute of Guangzhou Medical University, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Affiliated Cancer Hospital and Institute of Guangzhou Medical University has several departments that took part in Clinical trials: "Cancer Center of Guangzhou Medical University" - 35 trials